Quality of life, depression, and cytokine patterns in patients with chronic hepatitis C treated with antiviral therapy
Author(s) -
Katia Falasca,
Paola Mancino,
Claudio Ucciferri,
Margherita D’Alessandro,
Lamberto Manzoli,
Eligio Pizzigallo,
Chiara Conti,
Jacopo Vecchiet
Publication year - 2009
Publication title -
clinical and investigative medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.391
H-Index - 47
eISSN - 1488-2353
pISSN - 0147-958X
DOI - 10.25011/cim.v32i3.6110
Subject(s) - medicine , depression (economics) , ribavirin , ferritin , cytokine , quality of life (healthcare) , gastroenterology , cohort , hepatitis c , hepatitis c virus , chronic hepatitis , immunology , virus , nursing , economics , macroeconomics
To evaluate the effect of chronic hepatitis C and antiviral therapy on health-related quality of life (HRQoL), depression symptoms and cytokine patterns.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom